Trial Profile
A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2013
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Hydrochlorothiazide
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 14 Nov 2005 New trial record.